Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
roche
4
×
europe blog main
europe top stories
novartis
boston
boston blog main
boston top stories
cancer
clinical trials
deals
gene therapy
genentech
national
san francisco top stories
zolgensma
acquisitions
advanced therapies
atmp
avapritinib
avexis
billy dunn
biogen
biopharma
bioprocess insider
blueprint medicines
bms
brammer bio
bristol-myers squibb
cancer drugs
capmatinib
car-t
car-t chimeric antigen receptor
catalent
cell & gene
cell gene therapy
cell therapeutics
What
therapy
4
×
fda
approval
drug
gene
medicine
roche
therapeutics
access
address
advanced
approved
approves
atrophy
betting
billion
biopharma
blueprint
cancer
capacity
car
carries
cell
certain
consolidation
crispr
daily
deal
designed
duchenne
evrysdi
falcon
focus
friday
genetic
green
historic
home
intended
latest
Language
unset
Current search:
roche
×
therapy
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
